Fabio Pammolli

Presentation

Fabio Pammolli (January 11, 1965)

E-mail: f.pammolli@imtlucca.it ; pammolli@gmail.com

Mobile +39-348-8120691

Fabio served (2004-2012) as Director and President of the Executive Council of IMT Institute for Advanced Studies (www.imtlucca.it). As the Founding Director of the Institute, he presided over its establishment as an international research university. Unique within the Italian system, IMT represents a remarkable innovation in terms of organization of research, and selection and hiring procedures for faculty and students:

(https://www.imtlucca.it/whats_new/_press_review_files/IHT_Simplifying_Italy_to_lure_global_graduates.pdf).

He’s currently Professor of Economics and Management at IMT, where he coordinates the Ph.D in Economics and the research unit Axes (Analysis of compleX Economic Systems).

Fabio is the President of the CERM Foundation (www.cermlab.it), an independent research institute specialized in analyzing the sustainability of public finances and the economics of pensions and health. 

Fabio graduated in economics from the University of Pisa and he did his doctoral studies in economics and management at the Sant'Anna School of Advanced Studies. From 1991 to 2001 he was at the University of Siena, while from 2001 to 2004 he was a professor of economics and management at the University of Florence. He has visited several institutions including Northeastern University, MIT, and Stanford University. Since 2005, he is a Research Fellow at Boston University, Dept. of Physics (http://polymer.bu.edu/staff.html).

Fabio combines different methodologies to cover a variety of topics in economics of science and innovation, industrial economics, the economics of health and pensions, and network analysis of large socio-economic systems. He is a leading expert in the economic analysis of biotechnology and pharmaceuticals. He is currently writing a book on growth and instability in economic systems.

He has published in journals such as: Science, Nature Reviews, The Proceedings of the National Academy of Sciences (cover article, Dec. 27, 2005, vol. 102, n. 52), The Journal of the European Economics Association, The International Journal of Industrial Organization, Management Science, European Management Review, Physical Review E, Physica-A, Revue d'Economie Industrielle, Research Policy, Small Business Economics, Health Affairs, R&D Management, E. Journal of Health Economics, Europhysics Letters, Economics Letters (Google Scholar h index = 24; Scopus h index = 14).

He served as a member of the Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH), World Health Organization, coauthoring the report on Public Health, Innovation and Intellectual Property Rights (2006).

He has been a columnist for the Corriere della Sera (2010-onwards) and Il Sole 24 Ore (2008-9). Fabio served as member of the Scientific Committee, National Institutes of Health (2001 -2006) and of the Pension Expenditure Assessment Board, Ministry of Labor and Social Policies and Ministry of Economy and Finance (2011 – 2012). He has authored several reports for the European Commission, on the structure and competitiveness of European high-tech industries, such as pharmaceuticals, biotechnology, and medical devices.

He has participated in research projects sponsored by national and international agencies and foundations. He was the director of EPRIS (European Pharmaceutical Regulation and Innovation Systems), a research initiative supported by the Merck Foundation. He has given talks and lectures at, among the others: The Council of Foreign Relations, the Royal Institute of International Affairs, World Economic Forum, NBER, London School of Economics, MIT, Stanford University, Columbia University, UC Berkeley, the OECD, École des Mines, École Polytechnique, The John’s Hopkins University, the AAAS. 

Fabio Pammolli's Recent Publications in English:

- F. Pammolli, 2013, “Is Europe Evolving Toward an Integrated Research Area?” Science, vol- 339, Feb. 8. (with A. Chessa, A. Morescalchi, O. Penner, A. Petersen, M. Riccaboni).

- F. Pammolli, 2013, “Reputation and Impact in Academic Careers”, (with A. Petersen, H.E. Stanley, M. Riccaboni, O. Penner, S. Fortunato), submitted.

- F. Pammolli, 2013, "Weighted networks as randomly reinforced urn processes" (with G. Caldarelli, A. Chessa, I. Crimaldi), Physical Review E, forthcoming.

- F. Pammolli, 2013, “The Dynamics of Network Controllability in Interbank Markets” (with G. Caldarelli, S. Battiston, D. Delpini, M. Riccaboni), Nature Scientific Reports, submitted.

- F. Pammolli, 2013, “Networks Reconstructed”, Nature Physics, Vol. 9, March (with G. Caldarelli, A. Chessa, D. Delpini, M. Puliga).

- F. Pammolli, 2012, "Persistence and Uncertainty in The Academic Career", (with A. M. Petersen, M. Riccaboni, H. E. Stanley), Proceedings of the National Academy of Sciences, 109(14), 5213-5218

- F. Pammolli, 2012, "The Evolution of Complex Networks: A New Framework", (with G. Caldarelli, A. Chessa, I. Crimaldi), technical report 

- F. Pammolli, 2012, "Learning from Failures or Failing to Learn? Lessons from Pharmaceutical R&D", (with L. Magazzini, M. Riccaboni), European Management Review, 9(1), 45-58

- F. Pammolli, 2012, "The Value of Failures in Pharmaceuticals R&D", (with J. Chiou, L. Magazzini, M. Riccaboni), working paper (EIC Working Paper Series)

- F. Pammolli, 2012, "The Sustainability of European Health Care Systems: Beyond Income and Ageing", (with M. Riccaboni, L. Magazzini), The European Journal of Health Economics, October 2012, Volume 13, Issue 5, pp 623-634

- F. Pammolli, 2011, “The productivity crisis in pharmaceutical R&D”, (with L. Magazzini, M. Riccaboni), Nature Reviews, vol. 10, 428-438

- F. Pammolli, 2011, "Innovation and Corporate Dynamics: A Theoretical Framework", (with J. Growiec, M. Riccaboni),  working paper

- F. Pammolli, 2010, "Scale-free models for the structure of business firm networks", (with M. Kitsak, M. Riccaboni, S. Havlin, H.E. Stanley), Physical Review E, vol. 81

 - F. Pammolli, 2009, "Patent Disclosure and R&D Competition in Pharmaceuticals", (with L. Magazzini, M. Riccaboni, M.A. Rossi), Economics of Innovation and New Technology, 18(5), 467–486

- F. Pammolli, 2009, "A Breath of Fresh Air? Firm Types, Scale, Scope and Selection Effects in Drug Development", (with A. Arora, A. Gambardella, L. Magazzini), Management Science, 55(10), 1638-1653

- F. Pammolli, 2008, "The Size Variance Relationship of Business Firm Growth Rates", (with S.V. Buldyrev, M. Riccaboni, H.E. Stanley, L. Ponta), Proceedings of the National Academy of Sciences, 105(50), 19595-19600

- F. Pammolli, 2008, "Size dependent standard deviation for growth rates: Empirical results and theoretical modelling", (with B. Podobnik, D. Horvatic, F. Wang, H. E. Stanley, and I. Grosse), Physical Review E, 77(1)

- F. Pammolli, 2008, "On the Size Distribution of Business Firms", (with J. Growiec, M. Riccaboni, H.E. Stanley), Economics Letters, 98(2), 207-212

- F. Pammolli, 2007, "The Growth of Business Firms: Facts and Theory", (with S. V. Buldyrev, J. Growiec, M. Riccaboni, H. E. Stanley), Journal of the European Economic Association, 5(2/3), 574–584

- F. Pammolli, 2007, "Betweennes Centrality of Fractal and Non Fractal Scale Free Model Networks and Tests on Real Networks", (with M. Kitsak, S. Havlin. G. Paul, M. Riccaboni, H. E. Stanley), Physical Review E, 75(5)

- F. Pammolli, 2007, "Innovation and Industrial Leadership: Lessons from Pharmaceuticals", (with M. Riccaboni), Center for Transatlantic Relations, The Johns Hopkins University, Washington D.C.

- F.Pammolli, 2007, "Health Services in an Open Transatlantic Market: A European Perspective" (with M. Riccaboni, C. Bonassi), cap. IV, pp 77-97 in "Sleeping Giant – Awakening The Transatlantic Services Economy", edited by Daniel S. Hamilton and Joseph P. Quinlan, Center for Transatlantic Relations, The Johns Hopkins University, Washington D.C.

- F. Pammolli, 2007, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment", (with S.V. Buldyrev, M. Riccaboni, K. Yamasaki, D. Fu, K. Matia, H.E. Stanley), The European Physical Journal B, 57(2), 131–138

- F. Pammolli, 2007, "A Generalized Preferential Attachment Model for Business Firms Growth Rates. I. Empirical Evidence", (with D. Fu, S.V. Buldyrev, M. Riccaboni, K. Matia, K. Yamasaki, H.E. Stanley), The European Physical Journal B, 57 (2), 127–130

- F. Pammolli, 2006, "Preferential Attachment and Growth Dynamics in Complex Systems", (with K. Yamasaki, K. Matia, D. Fu, S. V. Buldyrev, M. Riccaboni, H. E. Stanley), Physical Review E, 74, 3, 035103(R)8

- Commission on Intellectual Property Rights, Innovation and Public Health, 2006, " Public Health, Innovation and Intellectual Property Rights", World Health Organization, Geneva, Switzerland.
The report is available at: http://www.who.int/intellectualproperty/report/en/

- F. Pammolli, 2005, "Intellectual Property, Technological Regimes and Market Dynamics", (with M. A. Rossi), Economia e Politica Industriale, 2/2005

- F. Pammolli, 2006, "Growth and Diversification Patterns of the Worldwide Pharmaceutical Industry", (with Giulio Bottazzi and Angelo Secchi), in G. Dosi e M. Mazzucato (eds), Knowledge Accumulation and Industry Evolution. The Case of Pharma-Biotech, Cambridge University Press, Cambridge, UK, pp. 208-233

- F. Pammolli, 2005, "The Growth of Business Firms: Theoretical Framework and Empirical Evidence", (with D. Fu, S.V. Buldyrev, M. Riccaboni, K. Yamasaki, K. Matia, H.E. Stanley) Proceedings of the National Academy of Sciences, 102(52), 18801-18806 (cover article)

- F. Pammolli, 2005, "Economic Evaluation of HIV Treatments: The I.CO.N.A. Cohort Study", (with M. Merito, A. Bonaccorsi, M. Riccaboni, G. Baio, C. Arici, A. D'Arminio Monforte, P. Pezzotti, D. Corsini, A. Tramarin, R. Cauda, V. Colangeli, G. Pastore), Health Policy, 74(3), 304-313

- F. Pammolli, 2005, "Medical Devices Competitiveness and Impact on Public Health Expenditure", (with M. Riccaboni, C. Oglialoro, L. Magazzini, N. Salerno, G. Baio), Entreprise Directorate-General, European Commission, Bruxelles.

- F. Pammolli, 2005, "Pharmaceuticals Analysed through the Lens of a Sectoral Innovation System", (with M. McKelvey, L. Orsenigo), Part II.3 in F. Malerba (Ed.), Sectoral Systems of Innovation. Concepts, Issues and Analyses of Six Major Sectors in Europe, Cambridge University Press

- F. Pammolli, 2004, "Statistical Properties of Business Firm Structure and Growth", (with K. Matia, D. Fu, S. V. Buldyrev, M. Riccaboni), Europhysics Letters, 67(3), 493-503

- F. Pammolli, 2004, "Market Structure and Drug Innovation", (with M. Riccaboni), Health Affairs, 23(1), 48-50

- F. Pammolli, 2004, "The Nature and Extent of the Market for Technology in Biopharmaceuticals" (with A. Arora, A. Gambardella, M. Riccaboni), Part 2, pp. 175-202, in F. Cesaroni, A. Gambardella e W. Garcia-Fontes (Eds.), R&D, Innovation and Competitiveness in the European Chemical Industry, Springer, Dordrecht, NL

- F. Pammolli, 2004, "Dynamic Competition in Pharmaceuticals: On Patent Expiry, Generic Penetration and Industry Structure", (with L. Magazzini, M. Riccaboni), European Journal of Health Economics, 5(2), 175-182

- F. Pammolli, 2004, "Technological Competencies in Networks of Innovators", (with M. Riccaboni), Chap. 6 in J. Cantwell, A. Gambardella, O. Granstrand (Eds.) The Economics and Management of Technological Diversification. Routledge studies in the modern world economy, Routledge, London, UK

- F. Pammolli, 2003, "On Size and Growth of Business Firms", (with G. De Fabritiis, M. Riccaboni) Physica A, 324(1-2), pp. 38-44

- F. Pammolli, 2003, "Technological Regimes and the Evolution of Networks. Lessons from Biotechnology and Pharmaceuticals", (with M. Riccaboni), International Journal of Technology Management, 25(3), pp. 334-349

- F. Pammolli, 2003, "Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry", (with M. Riccaboni), Chap. 2 in P. P. Saviotti (Ed.), Applied Evolutionary Economics: New Empirical Methods and Simulation Techniques, Edward Elgar, Cheltenham

- F. Pammolli, 2003, "Public Research and Industrial Innovation: A comparison of U.S. and European Innovation Systems in the Life Sciences", (with J. Owen-Smith, W.W. Powell, M. Riccaboni), Chap. 10 in A. Geuna, A. Salter, E. Steinmueller, (Eds.), Science and Innovation: Rethinking the Rationales for Funding and Governance, Edward Elgar, Cheltenham

- F. Pammolli, 2002, "Innovation and Competitiveness in European Biotechnology", (with A. Allansdottir, A. Bonaccorsi, A. Gambardella, M. Mariani, L. Orsenigo, , M. Riccaboni), Enterprise Papers n. 7, Enterprise Directorate-General, European Commission, Bruxelles.
The paper is also available at: http://ec.europa.eu/enterprise/library/enterprise-papers/pdf/enterprise_paper_07_2002.pdf

- F. Pammolli, 2002, "Technological Regimes and the Growth of Networks: An Empirical Analysis", (with M. Riccaboni), Small Business Economics, 19(3), 205-215

- F. Pammolli, 2002, "The Intensity of Competition after Patent Expiry in Pharmaceuticals: a Cross-country Analysis", (with L. Magazzini, L.Orsenigo), Revue d'Economie Industrielle, 99, 107-132

- F. Pammolli, 2002, "A Comparison of U.S. and European University-Industry Relations in the Life Sciences", (with J. Owen-Smith, W.W. Powell, M. Riccaboni), Management Science, 48(1), 24-43. Also in M. McKelvey & L. Orsenigo (Eds.), The Economics of Biotechnology, Volume II, 342-361, Edward Edgar, Cheltenham

- F. Pammolli, 2002, "On Firm Growth in Networks", (with M. Riccaboni), Research Policy, 31(8-9), 1405-1416

- F. Pammolli, 2002, "Europe and the United States: The Power of Networks. Lessons from Technology Transfer", (with J. Owen-Smith, , W.W. Powell, M. Riccaboni ), Biofutur, 222, 26-29

- F. Pammolli, 2001, "The Nature and the Extent of Markets for Technology", (with A. Arora, A. Gambardella, M. Riccaboni), CNRS, Collection Les Cahiers de l'Innovation, Cahier n. 37

- F. Pammolli, 2001, "Innovation and Corporate Growth in the Evolution of the Drug Industry", (with G. Bottazzi, G. Dosi, M. Lippi, , M. Riccaboni), International Journal of Industrial Organization, 19 (7), 1161-1187

- F. Pammolli, 2001, "Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry", (with L. Orsenigo, M. Riccaboni), Research Policy, 30(3), 485-508. Also in M. McKelvey & L. Orsenigo (Eds.), The Economics of Biotechnology, Volume II, 172-198, Edward Edgar, Cheltenham, UK

- F. Pammolli, 2001, "Variety and Irreversibility in Scientific and Technological Systems: the Evolution of an Industry Network", (with L. Orsenigo, M. Riccaboni), in A. Nicita, U. Pagano (Eds.), The Evolution of Economic Diversity, Routledge, London, 216-239

- F. Pammolli, 2001, "Global Competitiveness in Pharmaceuticals: A European Perspective" (with A. Gambardella, L. Orsenigo), DG Enterprise, European Commission, 2001.

 - F. Pammolli, 1998, "The Evolution of Knowledge and the Dynamics of an Industry Network" (with A. Bonaccorsi, L. Orsenigo, M. Riccaboni, G. Turchetti), The Journal of Management and Governance, 1(2), 147-175

 - F. Pammolli, 1996, "The Changing Boundaries of System Companies" (with A. Bonaccorsi, S. Tani), The International Business Review, 5(6), 539-560

Fabio Pammolli's Recent Publications in Italian:

- F. Pammolli, 2011, "La distribuzione dei farmaci tra progetti di riforma e incertezze", (with N. C. Salerno), Economia e politica industriale, 38(2), 125-148.

- F. Pammolli, 2011, "Sistemi sanitari regionali alla sfida del federalismo: una proposta per il finanziamento federalista della sanità", (with N. C. Salerno), EyesREg Giornale di Scienze Regionali, 1(1).

- F. Pammolli, 2010, "Come velocizzare il passaggio al sistema di calcolo contributivo delle pensioni? Una proposta operativa per rafforzare l'aggancio alla vita attesa", (with N. C. Salerno),  Rivista del diritto della sicurezza sociale 1/2010, 109-122.

- F. Pammolli, 2009, "Requisiti anagrafici di accesso alle pensioni differenziati tra pilastro pubblico e pilastro privato, per riformare il welfare system rispettando le scelte individuali", (with N. C. Salerno),  Rivista del diritto della sicurezza sociale 2/2009, 433-440.

- F. Pammolli, 2009, "Corte di giustizia, età di pensionamento di vecchiaia per le donne e riforma delle pensioni e del welfare in Italia", (with N. C. Salerno),  Rivista del diritto della sicurezza sociale 1/2009, 143-148.

- F. Pammolli, 2008, "La Sanità in Italia - Federalismo, regolazione dei mercati, sostenibilità delle finanze pubbliche", (with N. C. Salerno), Il Mulino, Bologna

- F. Pammolli, 2008, "Il sistema pensionistico: quale riforma?", (with N. C. Salerno), parte II, cap.9, pp. 335 - 353 in: A cura di Luciano Guerzoni, La Riforma del Welfare - Dieci anni dopo la «Commissione Onofri», Il Mulino, Bologna

- F. Pammolli, 2008, "I livelli essenziali di assistenza, la regolazione e la riforma multipilastro", (with N. C. Salerno, G. Turchetti), parte IV, cap. 2, pp. 263-292 in A cura di Antonio Pedone, La Sanità in Italia - Qualità del servizio e sostenibilità finanziaria, Edizioni Il Sole 24 ORE, Milano

- F. Pammolli, 2008, "Regolazione di prezzo, innovazione e ciclo di vita dei prodotti: per una riforma del sistema di pricing nel settore farmaceutico", (with C. Bonassi, M. Riccaboni, N. C. Salerno), cap. III, pp 79-132 in "La salute e il mercato. La ricerca farmaceutica tra Stato, industria e cittadini", a cura di Giorgio Macciotta, collana Ricerche di Astrid, Il Sole 24 ORE, Milano

- F. Pammolli, 2008, "La distribuzione al dettaglio dei farmaci: tra regolazione efficiente e mercato", (with N. C. Salerno), cap. VI, pp 153-198 in "La salute e il mercato. La ricerca farmaceutica tra Stato, industria e cittadini", a cura di Giorgio Macciotta collana Ricerche di Astrid, Il Sole 24 ORE, Milano

- F. Pammolli, 2007, "Politiche di liberalizzazione e concorrenza in Italia", (with C. Cambini, A. Giannaccari), Il Mulino - Prismi, Bologna

- F. Pammolli, 2007, "Introduzione. Liberalizzazioni e concorrenza in Italia", (with C. Cambini, A. Giannaccari), pp. 7-26 in F. Pammolli, C. Cambini, A. Giannaccari, Politiche di liberalizzazione e concorrenza in Italia., Il Mulino - Prismi, Bologna

- F. Pammolli, 2007, "Il settore farmaceutico tra barriere alla concorrenza e regolazione sul lato del consumo" (with M. Riccaboni, N. C. Salerno), cap. XI, pp. 325-350 in F. Pammolli, C. Cambini, A. Giannaccari, Politiche di liberalizzazione e concorrenza in Italia., Il Mulino - Prismi, Bologna

- F. Pammolli, 2007, "Spesa sanitaria, demografia, istituzioni", cap. 7, pp. 103-125 in A cura di M. Madìa, introduzione di E. Letta, Un Welfare Anziano - Invecchiamento della popolazione o ringiovanimento della società?, Il Mulino - Arel, Bologna

- F. Pammolli, 2006, "Il sistema di istruzione italiano: un confronto internazionale", (with G. Papa, N.C. Salerno), vol. 13, parte I, cap. 4, pp. 81-125 in A cura di Paola Reggiani Gelmini, Michele Tiraboschi, Prefazione di Letizia Moratti, Scuola, Università e Mercato del lavoro dopo la Riforma Biagi - Le politiche per la transizione dai percorsi educativi e formativi al mercato del lavoro, Collana Adapt - Fondazione "Marco Biagi", Giuffré Editore, Milano

- F. Pammolli, 2005, "Nuove Imprese, Concorrenza e Produttività", Le nuove imprese in Italia 1998-2002:Osservatorio Unioncamere sulla Demografia delle Imprese, Franco Angeli, 2005

- F. Pammolli, 2005, Modelli e Strategie di Marketing, Franco Angeli, Milano

- F. Pammolli, 2004, Sicurezza, Innovazione, Crescita, (with A.Paci, M. Riccaboni ), Il Mulino, Bologna